1-161548546-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000443193.6(FCGR3A):c.194G>A(p.Ser65Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.111 in 1,149,004 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
ENST00000443193.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FCGR3A | NM_000569.8 | c.194G>A | p.Ser65Asn | missense_variant | 3/5 | ENST00000443193.6 | NP_000560.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FCGR3A | ENST00000443193.6 | c.194G>A | p.Ser65Asn | missense_variant | 3/5 | 1 | NM_000569.8 | ENSP00000392047 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 32471AN: 127910Hom.: 0 Cov.: 35 FAILED QC
GnomAD3 exomes AF: 0.0964 AC: 17995AN: 186676Hom.: 5 AF XY: 0.0883 AC XY: 9001AN XY: 101962
GnomAD4 exome AF: 0.111 AC: 127438AN: 1149004Hom.: 15 Cov.: 65 AF XY: 0.117 AC XY: 67072AN XY: 572096
GnomAD4 genome Data not reliable, filtered out with message: InbreedingCoeff AF: 0.254 AC: 32490AN: 127974Hom.: 0 Cov.: 35 AF XY: 0.257 AC XY: 16109AN XY: 62600
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at